Search research articles
Contact Us
Filters
Showing results (151-160 of 169) with videos related to
Page
of 17
Sort By:
Nature
|
September 15, 2015
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
Philipp Rathert, Mareike Roth, Tobias Neumann, et al.
Plos One
|
July 14, 2022
Interrogating intervention delivery and participants' emotional states to improve engagement and implementation: A realist informed multiple case study evaluation of Engager
Lauren Weston, Sarah Rybczynska-Bunt, Cath Quinn, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
March 18, 2026
Non-Pharmacological Breathlessness Action Plans for People with COPD and Their Support People: A Scoping Review and Survey of Current Practice
Tim Luckett, Mary M Roberts, Muneeba Tariq Chaudhry, et al.
Journal of Medicinal Chemistry
|
February 26, 2016
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
Laetitia J Martin, Manfred Koegl, Gerd Bader, et al.
Chemmedchem
|
December 4, 2020
Getting a Grip on the Undrugged: Targeting β-Catenin with Fragment-Based Methods
Dirk Kessler, Moriz Mayer, Stephan K Zahn, et al.
Biorxiv : the Preprint Server for Biology
|
February 7, 2023
Combined KRAS<sup>G12C</sup> and SOS1 inhibition enhances and extends the anti-tumor response in KRAS<sup>G12C</sup>-driven cancers by addressing intrinsic and acquired resistance
Venu Thatikonda, Hengyu Lu, Sabine Jurado, et al.
Thrombosis Research
|
January 18, 2026
Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study
, Isabelle Mahé, Skerdi Haviari, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
August 17, 2022
Evaluation of a complex intervention for prisoners with common mental health problems, near to and after release: the Engager randomised controlled trial
Richard Byng, Tim Kirkpatrick, Charlotte Lennox, et al.
Mabs
|
December 9, 2024
A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer
Peter Jung, Stefan P Glaser, Jing Han, et al.
Cancer Discovery
|
August 21, 2020
BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition
Marco H Hofmann, Michael Gmachl, Juergen Ramharter, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 169) with videos related to
Sort By:
Page
of 17
Nature
|
September 15, 2015
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
Philipp Rathert, Mareike Roth, Tobias Neumann, et al.
Plos One
|
July 14, 2022
Interrogating intervention delivery and participants' emotional states to improve engagement and implementation: A realist informed multiple case study evaluation of Engager
Lauren Weston, Sarah Rybczynska-Bunt, Cath Quinn, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
March 18, 2026
Non-Pharmacological Breathlessness Action Plans for People with COPD and Their Support People: A Scoping Review and Survey of Current Practice
Tim Luckett, Mary M Roberts, Muneeba Tariq Chaudhry, et al.
Journal of Medicinal Chemistry
|
February 26, 2016
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
Laetitia J Martin, Manfred Koegl, Gerd Bader, et al.
Chemmedchem
|
December 4, 2020
Getting a Grip on the Undrugged: Targeting β-Catenin with Fragment-Based Methods
Dirk Kessler, Moriz Mayer, Stephan K Zahn, et al.
Biorxiv : the Preprint Server for Biology
|
February 7, 2023
Combined KRAS<sup>G12C</sup> and SOS1 inhibition enhances and extends the anti-tumor response in KRAS<sup>G12C</sup>-driven cancers by addressing intrinsic and acquired resistance
Venu Thatikonda, Hengyu Lu, Sabine Jurado, et al.
Thrombosis Research
|
January 18, 2026
Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study
, Isabelle Mahé, Skerdi Haviari, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
August 17, 2022
Evaluation of a complex intervention for prisoners with common mental health problems, near to and after release: the Engager randomised controlled trial
Richard Byng, Tim Kirkpatrick, Charlotte Lennox, et al.
Mabs
|
December 9, 2024
A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer
Peter Jung, Stefan P Glaser, Jing Han, et al.
Cancer Discovery
|
August 21, 2020
BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition
Marco H Hofmann, Michael Gmachl, Juergen Ramharter, et al.
Page
of 17